# Isoniazid

NDC: 0555-0071
Generic name: Isoniazid
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 19720901
Marketing ended: 20270630
FDA application: ANDA080937

## Active ingredients

- ISONIAZID: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0555-0071"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0555-0071
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9499f1cf-2f46-4047-8b71-90aee7dee854